What are the side effects of Valganciclovir? Common adverse reactions and coping strategies

Valganciclovir is a drug used to treat and prevent cytomegalovirus (CMV) infection. Although it plays an important role in clinical practice, it may also cause certain side effects. Understanding these side effects and responding accordingly is critical to ensuring the safety and effectiveness of treatment.

Common side effects of Vancevir include hematological abnormalities, gastrointestinal reactions, liver damage and kidney problems. The most common side effects in patients while using this drug are myelosuppression, manifested by leukopenia (especially neutropenia), anemia, and thrombocytopenia. Because Vancevir inhibits the DNA synthesis of viruses, similar to some antiviral drugs, it may also affect the DNA synthesis of normal cells, especially bone marrow cells. Myelosuppression may lead to a decline in immune system function, making patients susceptible to infection. Therefore, regular blood routine examinations are required during treatment to detect hematological abnormalities in a timely manner. In patients who develop severe myelosuppression, doctors may consider adjusting the dose or temporarily discontinuing the drug.

In addition to hematological problems, gastrointestinal discomfort is one of the common side effects of taking Vancevir. These discomforts include nausea, vomiting, diarrhea and abdominal pain, which may affect the patient's daily life. Gastrointestinal symptoms are often noticeable early in drug treatment, and many patients gradually adapt to the drug over time. If gastrointestinal discomfort is severe, it is recommended that patients take medication after meals or consult a doctor to adjust the medication regimen to reduce discomfort.

Liver damage is also a possible side effect when using Vancevir. Although it is rare, you still need to be vigilant. Symptoms of impaired liver function include jaundice, liver discomfort, etc., which may lead to liver failure in severe cases. During the treatment process, especially in patients taking Vancevir for a long time, liver function monitoring should be carried out regularly, especially the levels of ALT, AST and other liver enzymes. If liver function abnormalities are found, dose reduction or discontinuation may be required, and necessary therapeutic intervention may be required.

Reference materials:https://go.drugbank.com/drugs/DB01610